Unknown

Dataset Information

0

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.


ABSTRACT:

Background

The prognostic value of preoperative controlling nutritional status (CONUT) has been reported in many malignancies. In present study, we aimed to clarify the prognostic impact of CONUT in gastric cancer (GC) receiving curative resection and adjuvant chemotherapy.

Methods

We retrospectively reviewed 697 consecutive patients undergoing curative surgery followed by adjuvant chemotherapy for Stage II-III GC between November 2000 and September 2012. Patients were classified into high (?3) and low (?2) CONUT groups according to the receiver operating characteristic (ROC) analysis.

Results

Of the included patients, 217 (31.1%) belonged to the high CONUT group. The high CONUT group had a significantly lower 5-year cancer-specific survival (CSS) rate than the low CONUT group (39.3 vs. 55.5%, P?ConclusionsCONUT score is considered a useful nutritional marker for predicting prognosis in stage II-III GC patients undergoing curative resection and adjuvant chemotherapy, and may help to facilitate the planning of preoperative nutritional interventions.

SUBMITTER: Liu X 

PROVIDER: S-EPMC6022496 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.

Liu Xuechao X   Zhang Deyao D   Lin Enzi E   Chen Yongming Y   Li Wei W   Chen Yingbo Y   Sun Xiaowei X   Zhou Zhiwei Z  

BMC cancer 20180628 1


<h4>Background</h4>The prognostic value of preoperative controlling nutritional status (CONUT) has been reported in many malignancies. In present study, we aimed to clarify the prognostic impact of CONUT in gastric cancer (GC) receiving curative resection and adjuvant chemotherapy.<h4>Methods</h4>We retrospectively reviewed 697 consecutive patients undergoing curative surgery followed by adjuvant chemotherapy for Stage II-III GC between November 2000 and September 2012. Patients were classified  ...[more]

Similar Datasets

| S-EPMC8421996 | biostudies-literature
| S-EPMC9895366 | biostudies-literature
| S-EPMC6833132 | biostudies-literature
| S-EPMC7413386 | biostudies-literature
| S-EPMC6567813 | biostudies-literature
| S-EPMC7850023 | biostudies-literature
| S-EPMC7382444 | biostudies-literature
| S-EPMC5623525 | biostudies-literature
| S-EPMC9182995 | biostudies-literature
| S-EPMC7171067 | biostudies-literature